← All indications
Thromboangiitis Obliterans
A non-atherosclerotic, inflammatory thrombotic disease that commonly involves small and medium-sized arteries or veins in the extremities. It is characterized by occlusive THROMBOSIS and FIBROSIS in the vascular wall leading to digital and limb ISCHEMIA and ulcerations. Thromboangiitis obliterans is highly associated with tobacco smoking.
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (1)
Phase 2 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 2 Indications (15)
- Biostar
- Stempeutics Research Pvt Ltd
- Seoul National University
- All India Institute of Medical Sciences
- Caladrius Biosciences
- Catholic University of Korea
- AMRI Hospital
- Stanley Medical College
- Madras Medical College
- Medanta - The Medicity
- Nightingale Hospital
- Sri Jayadeva Institute of Cardiovascular Sciences & Research
- Sri Ramachandra Medical College, Chennai
- M.S. Ramaiah Medical College, Bangalore, India
- Melaka Manipal Medical College